Clinical trial

Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment

NCT01100125

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE4

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2013-10-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

sitagliptinDRUG · verified · RxNorm: sitagliptin

insulin dose increaseDRUG

Sponsors & collaborators

Seoul National University Bundang Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01100125 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.